[Treatment of non-small cell bronchopulmonary carcinoma with the combination of cyclophosphamide, adriamycin and cisplatin].
Twenty three patients with small non oat-cell lung cancer were treated with a combination of cyclophosphamide, adriamycin and cisplatin chemotherapy. The treatment produced 30.4 per 100 objective responses (7 cases), with complete remission in 2 cases and partial remission in 5 cases. The remission duration was 7.5 and 6 months respectively. The initial "status performans" is important for the response.
D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy*; D002945:Cisplatin / Q000008:administration & dosage; D003520:Cyclophosphamide / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged
D004317:Doxorubicin; D003520:Cyclophosphamide; D002945:Cisplatin
Tratamiento del carcinoma broncopulmonar "no indiferenciado de células pequeñas" con la asociación de ciclofosfamida, adriamicina y cis-platino.